featured
Prophylactic ACE Inhibitors and Overall Survival in Duchenne Muscular Dystrophy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
European Heart Journal
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Association Between Prophylactic Angiotensin-Converting Enzyme Inhibitors and Overall Survival in Duchenne Muscular Dystrophy—Analysis of Registry Data
Eur Heart J 2021 Mar 22;[EPub Ahead of Print], R Porcher, I Desguerre, H Amthor, B Chabrol, F Audic, F Rivier, A Isapof, V Tiffreau, E Campana-Salort, F Leturcq, S Tuffery-Giraud, R Ben Yaou, D Annane, P Amédro, C Barnerias, HM Bécane, A Béhin, D Bonnet, G Bassez, M Cossée, G de La Villéon, C Delcourte, A Fayssoil, B Fontaine, F Godart, S Guillaumont, E Jaillette, P Laforêt, S Leonard-Louis, F Lofaso, M Mayer, RJ Morales, C Meune, D Orlikowski, C Ovaert, H Prigent, M Saadi, M Sochala, C Tard, G Vaksmann, U Walther-Louvier, B Eymard, T Stojkovic, P Ravaud, D Duboc, K WahbiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.